Ioannis I. Varthalitis

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Treatment of an unresectable cardiac angiosarcoma using paclitaxel and image guided radiotherapy: Case report and literature review.

Treatment of an unresectable cardiac angiosarcoma using paclitaxel and image guided radiotherapy: Case report and literature review.

Journal: Clinical and translational radiation oncology
Published: January 10, 2023

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.

Journal: Oncology letters
Published: October 30, 2021

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma.

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma.

Journal: Cancers
Published: November 12, 2020

Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?

Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?

Journal: Cancers
Published: May 30, 2020

Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.

Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.

Journal: Journal of oncology
Published: February 17, 2020

Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental.

Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental.

Journal: Anticancer research
Published: November 05, 2019

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.

Journal: PloS one
Published: September 06, 2019

Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative.

Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative.

Journal: Oncotarget
Published: May 16, 2019

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Journal: Targeted oncology
Published: November 30, 2018

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.

Journal: ESMO open
Published: November 19, 2018

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.

Journal: Oncotarget
Published: June 29, 2018

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.

Journal: Medical oncology (Northwood, London, England)
Published: May 14, 2018
Showing 1-12 of 27

Last Updated: 09/26/2026